Thermosensitive Liposomes for Bladder Tumor Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current intravesical chemotherapy for bladder tumors is limited by the urothelial layer's barrier, which restricts deep penetration of cytostatic drugs, resulting in inadequate treatment efficacy, especially for tumors beyond the urothelial layer.
Innovation Solution
Development of stimuli-sensitive nanocarrier systems, specifically thermosensitive liposomes comprising phosphatidylcholine and phosphatidyloligoglycerol, which release active ingredients in response to localized heating, allowing targeted delivery of cytostatic agents directly to the bladder wall, bypassing the urothelial barrier.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If intravesical chemotherapy is used to treat bladder tumors, then the treatment can be administered directly to the bladder, but the urothelial layer acts as an effective barrier that limits drug penetration depth
Solution Approach 1:
The patent changes the physical state and properties of the drug delivery system by using thermosensitive liposomes that undergo phase transition at specific temperatures. The liposomes remain stable at body temperature (37°C) but release their cargo when exposed to localized heating (40-42°C), thereby overcoming the urothelial barrier and achieving deep tissue penetration
Solution Approach 2:
The patent exploits the phase transition property of thermosensitive lipids within the liposome membrane. At temperatures below the transition point, the membrane is in a gel phase that maintains structural integrity and prevents drug leakage. Upon localized heating above the transition temperature, the membrane transitions to a liquid crystalline phase, causing rapid drug release directly at the tumor site
2Ease of operation
If conventional chemotherapy instillation is administered, then the procedure is simple and can be repeated, but the drug penetration depth is insufficient to treat tumors beyond the urothelial layer
Solution Approach 1:
The patent introduces thermosensitive liposomes as an intermediary carrier system between the chemotherapy drug and the tumor tissue. These liposomes facilitate deep penetration through the urothelial barrier and release the drug at the target site through temperature-triggered phase transition, thereby achieving both ease of administration and deep tissue penetration
Solution Approach 2:
The patent uses composite liposomal structures composed of thermosensitive phospholipids, cholesterol, and encapsulated chemotherapy agents. This composite material combines the stability needed for circulation and storage with the temperature-responsive release capability, enabling both simple administration and deep tissue penetration
3Length of stationary object
If thermosensitive liposomes are used for targeted drug delivery, then deep tissue penetration is achieved, but the system requires localized heating which adds treatment complexity
Solution Approach 1:
The patent designs the thermosensitive liposome system to serve multiple functions: it acts as a stable drug carrier during circulation, provides targeted release through phase transition, and enables deep tissue penetration. The localized heating requirement is minimized by using mild temperature elevation (40-42°C) that can be achieved through simple external heating devices, making the system versatile and clinically applicable
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables high tissue levels of cytostatic agents down to the tunica muscularis, improving tumor control with reduced systemic side effects and potentially replacing conventional intravesical chemotherapy.
Implementation Method 1
thermosensitive liposomes... which release active ingredients in response to localized heating
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to stereospecific lipids for the locoregional therapy with long-term circulating stimuli-sensitive nanocarrier systems. A preferred embodiment thereof is a thermosensitive liposome for treating tumors, especially urinary bladder tumors and other localized tumors.